Director of Communications, University of Michigan Rogel Cancer
Fawcett leads a team of communicators who produce targeted, innovative communication for the Rogel Cancer Center’s research and clinical enterprises. Prior to Michigan Medicine, Fawcett was a reporter at the Detroit News and editor for a web-based community for people with disabilities.
Health Lab
Researchers from the University of Michigan Health Rogel Cancer Center have developed a monitoring system using a research genetics program to trigger alerts about cancer patients suspected to have the DPYD gene variant.
Health Lab
For people with expensive prescription drugs, switching plans could save them thousands of dollars in copays. And a simple tool can help people easily compare out-of-pockets expenses for anyone with a Medicare Part D prescription plan.
News Release
Technology developed at U-M uses sound waves to destroy tissue, providing a new type of cancer therapy
Health Lab
A free online tool could potentially save some prostate cancer patients more than $9,000 in out-of-pocket drug costs, a Michigan Medicine study finds.
Health Lab
A potential drug candidate called ONC201 nearly doubled survival for patients with diffuse midline glioma and DIPG.
Health Lab
An analysis finds that up to millions of dollars could be saved annually on cancer immunotherapy treatments across the Veterans Health Administration by reconsidering how those drugs are delivered.
News Release
The National Cancer Institute has awarded the U-M Rogel Cancer Center a grant worth $37 million over five years and renewed the center’s designation as a “comprehensive cancer center.”
Health Lab
For thyroid cancer, experts examine the current state of overdiagnosis, new therapies, health equity concerns and more.
Health Lab
Financial toxicity of cancer impacts partners’ quality of life, with people reporting pain, fatigue and sleep issues tied to missed work and medical bills
Health Lab
Michigan Medicine researchers used microfluidic devices to track what happens to cancer cells as they migrate and take root in the brain.
Health Lab
Protein degrader shows promise against STAT5, which plays a role in leukemia and other cancers
Health Lab
University of Michigan Rogel Cancer Center researchers find ZMYND8 gene plays a critical role in conferring radiation resistance on brain tumors with IDH1 mutation.
Health Lab
New research suggests gastrointestinal diseases caused by immune system T cells could be mitigated by bolstering a common enzyme.
Health Lab
In a clinical trial, adding interferon treatment with a bone marrow transplant bolstered outcomes for patients with advanced, high-risk leukemia.
Health Lab
Targeting this inside-the-cell checkpoint could potentially improve response to cancer immunotherapy.
